These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 19336268)

  • 1. Determination of pharmaceutical compounds in hospital effluents and their contribution to wastewater treatment works.
    Langford KH; Thomas KV
    Environ Int; 2009 Jul; 35(5):766-70. PubMed ID: 19336268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Source to sink tracking of selected human pharmaceuticals from two Oslo city hospitals and a wastewater treatment works.
    Thomas KV; Dye C; Schlabach M; Langford KH
    J Environ Monit; 2007 Dec; 9(12):1410-8. PubMed ID: 18049781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of pharmaceuticals of various therapeutic classes by solid-phase extraction and liquid chromatography-tandem mass spectrometry analysis in hospital effluent wastewaters.
    Gómez MJ; Petrović M; Fernández-Alba AR; Barceló D
    J Chromatogr A; 2006 May; 1114(2):224-33. PubMed ID: 16546199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment.
    Verlicchi P; Al Aukidy M; Galletti A; Petrovic M; Barceló D
    Sci Total Environ; 2012 Jul; 430():109-18. PubMed ID: 22634557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining the fraction of pharmaceutical residues in wastewater originating from a hospital.
    Ort C; Lawrence MG; Reungoat J; Eaglesham G; Carter S; Keller J
    Water Res; 2010 Jan; 44(2):605-15. PubMed ID: 19717180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures.
    Sim WJ; Lee JW; Lee ES; Shin SK; Hwang SR; Oh JE
    Chemosphere; 2011 Jan; 82(2):179-86. PubMed ID: 21040946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary study of physico-chemical treatment options for hospital wastewater.
    Gautam AK; Kumar S; Sabumon PC
    J Environ Manage; 2007 May; 83(3):298-306. PubMed ID: 16824671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare facility effluents as point sources of select pharmaceuticals to municipal wastewater.
    Nagarnaik PM; Batt AL; Boulanger B
    Water Environ Res; 2012 Apr; 84(4):339-45. PubMed ID: 22834222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of human pharmaceuticals in water samples by high performance liquid chromatography-tandem mass spectrometry.
    Nebot C; Gibb SW; Boyd KG
    Anal Chim Acta; 2007 Aug; 598(1):87-94. PubMed ID: 17693311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of hospital wastewater: an appraisal.
    Pauwels B; Verstraete W
    J Water Health; 2006 Dec; 4(4):405-16. PubMed ID: 17176811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of contaminants of emerging concern removal, discharge, and water quality hazards among centralized and on-site wastewater treatment system effluents receiving common wastewater influent.
    Du B; Price AE; Scott WC; Kristofco LA; Ramirez AJ; Chambliss CK; Yelderman JC; Brooks BW
    Sci Total Environ; 2014 Jan; 466-467():976-84. PubMed ID: 23988745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence and removal of pharmaceuticals, caffeine and DEET in wastewater treatment plants of Beijing, China.
    Sui Q; Huang J; Deng S; Yu G; Fan Q
    Water Res; 2010 Jan; 44(2):417-26. PubMed ID: 19674764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs, diagnostic agents and disinfectants in wastewater and water--a review.
    Kümmerer K
    Schriftenr Ver Wasser Boden Lufthyg; 2000; 105():59-71. PubMed ID: 10842795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of pharmaceuticals in Taiwan's surface waters: impact of waste streams from hospitals and pharmaceutical production facilities.
    Lin AY; Tsai YT
    Sci Total Environ; 2009 Jun; 407(12):3793-802. PubMed ID: 19345984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of pharmaceuticals in indirect potable reuse systems using solid-phase extraction and liquid chromatography-tandem mass spectrometry.
    Busetti F; Linge KL; Heitz A
    J Chromatogr A; 2009 Jul; 1216(31):5807-18. PubMed ID: 19560149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence and removal of pharmaceuticals in wastewater treatment plants at the Spanish Mediterranean area of Valencia.
    Gracia-Lor E; Sancho JV; Serrano R; Hernández F
    Chemosphere; 2012 Apr; 87(5):453-62. PubMed ID: 22221664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling of hospital wastewater pollution by pharmaceuticals: first results of Mediflux study carried out in three French hospitals.
    Mullot JU; Karolak S; Fontova A; Levi Y
    Water Sci Technol; 2010; 62(12):2912-9. PubMed ID: 21123922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain).
    Santos JL; Aparicio I; Alonso E
    Environ Int; 2007 May; 33(4):596-601. PubMed ID: 17084895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
    Radjenović J; Petrović M; Barceló D
    Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of residual organic macromolecules produced in biological wastewater treatment processes on removal of pharmaceuticals by NF/RO membranes.
    Kimura K; Iwase T; Kita S; Watanabe Y
    Water Res; 2009 Aug; 43(15):3751-8. PubMed ID: 19564034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.